results of the open-label, pragmatic, cluster-randomised TICOSPA trial

Ann Rheum Dis. 2021 Nov; 80(11):1436-1444.

Objectives:

To compare the benefits of a tight-control/treat-to-target strategy (TC/T2T) in axial spondyloarthritis (axSpA) with those of usual care (UC).

 

https://pubmed.ncbi.nlm.nih.gov/33958325/